Image

STEMI Treatment Optimization by Ischemic Postconditioning and IVUS Guidance

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The purpose of is study is to investigate whether ischemic postconditioning (iPOST) and intravascular ultrasound-guided (IVUS) percutaneous coronary intervention (PCI) improve the clinical outcome of patients with ST-segment elevation myocardial infarction treated with primary PCI.

Eligibility

Inclusion Criteria:

  • Age ≥18 years
  • Acute onset of chest pain with <12 hours duration
  • STEMI as characterized by 2 mm ST elevation in 2 or more V1 through V4 leads or presumed new left bundle branch block with minimum of 1 mm concordant ST elevation or 1 mV ST-segment elevation in the limb lead (II, III and aVF, I, aVL) and V4-V6 or ST depression in 2 or more V1 through V4 leads indicating posterior AMI.

Exclusion Criteria (iPOST2):

        Pre-PCI TIMI flow 0 or 1 Potential pregnancy Inability to provide informed consent
        Unwillingness to consent Unavoidable to use thrombectomy Spontaneous coronary artery
        dissection Time from symptoms onset to PPCI > 12 hours Culprit in bypass graft Other reason
        for not including the patient
        Exclusion Criteria (iSTEMI):
        Potential pregnancy Inability to understand information in order to provide informed
        consent Unwillingness to consent Spontaneous coronary artery dissection Time from symptoms
        inset to PPCI > 12 hours Culprit in bypass graft Other reason

Study details

ST Elevation Myocardial Infarction

NCT04775914

Thomas Engstrom

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.